FEROLLA, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 1.387
EU - Europa 1.135
AS - Asia 442
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.975
Nazione #
US - Stati Uniti d'America 1.384
IE - Irlanda 299
UA - Ucraina 272
SE - Svezia 166
SG - Singapore 149
HK - Hong Kong 116
IT - Italia 113
VN - Vietnam 94
DE - Germania 79
FI - Finlandia 66
CN - Cina 44
RU - Federazione Russa 44
GB - Regno Unito 32
FR - Francia 24
KR - Corea 21
CZ - Repubblica Ceca 12
TR - Turchia 11
BE - Belgio 7
CH - Svizzera 7
AT - Austria 6
UZ - Uzbekistan 4
BR - Brasile 3
CO - Colombia 3
RO - Romania 3
GR - Grecia 2
MX - Messico 2
NL - Olanda 2
PE - Perù 2
AM - Armenia 1
AR - Argentina 1
CA - Canada 1
EU - Europa 1
KH - Cambogia 1
LB - Libano 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
Totale 2.975
Città #
Chandler 304
Dublin 299
Jacksonville 156
Singapore 124
San Mateo 123
Hong Kong 116
Dong Ket 94
Boardman 83
Santa Clara 59
Ann Arbor 57
Medford 53
Princeton 53
Andover 42
Wilmington 37
Beijing 31
Altamura 26
Perugia 26
Seoul 21
Lawrence 18
Helsinki 14
Munich 13
Saint Petersburg 13
Izmir 11
Woodbridge 11
Ashburn 10
Brno 10
Norwalk 10
Redmond 10
Auburn Hills 7
Brussels 7
Foligno 7
Dallas 6
Des Moines 6
Falls Church 4
Shanghai 4
Florence 3
Lausanne 3
New York 3
Den Haag 2
Edinburgh 2
Iglesias 2
Los Angeles 2
Padova 2
Rockville 2
Salvador 2
San Paolo di Civitate 2
Sesto Fiorentino 2
Taranto 2
Trujillo 2
Auckland 1
Avellino 1
Avigliano 1
Barletta 1
Bogotá 1
Bronx 1
Bucharest 1
Buenos Aires 1
Cento 1
Cochrane 1
Falkenstein 1
Formigine 1
Fuzhou 1
Glasgow 1
Grumo Appula 1
Islington 1
Itapipoca 1
Lanzhou 1
Ludwigshafen 1
Medellín 1
Mexico City 1
Moscow 1
Odesa 1
Osimo 1
Palestrina 1
Pereira 1
Philadelphia 1
Phnom Penh 1
Podgorica 1
Pomezia 1
Prague 1
Reghin 1
Rome 1
San Severo 1
Stockholm 1
Timisoara 1
Torino 1
Trieste 1
Verona 1
Yerevan 1
Totale 1.936
Nome #
Effect of EPA on Neonatal Pig Sertoli Cells “In Vitro”: A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies 118
(111)In-pentetreotide SPET/CT in carcinoid tumours: is the role of hybrid systems advantageous in abdominal or thoracic lesions? 112
Aspetti clinici dei tumori neuroendocrini 96
Tumori neuroendocrini toracici ben differenziati: la corretta gestione clinica 87
Typical Carcinoids of the Lung: Multicentric Forms, Lymph-node Metastases and Long-term Survival in 83 Patients 87
Tumori Neuroendocrini del Polmone, aspetti medici 85
La caratterizzazione biologica dei NET: ruolo diagnostico e prognostico dei marcatori neuroendocrini 83
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours 80
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 73
Prevalenza del fenotipo neuroendocrino nelle neoplasie del timo 69
Typical Carcinoid of the lung: multicentric forms, lymph-node metastases and long-term survival in 83 patients. 70th Annual International Scientific Assembly of the American College of Chest Physicians (ACCP) 68
Neuroendocrine Features Of Well Differentiated Human Neuroendocrine Lung Tumors - Atti XXII Congresso Nazionale Società Italiana Endocrino Chirurgia 68
Prevalence of the neuroendocrine phenotype in thymus neoplasms. 68
Endoscopia virtuale e tecniche di ricostruzione tridimensionali con TC nella diagnosi e nel follow-up delle lesioni tracheobronchiali - 105° Congresso Società Italiana di Chirurgia 67
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy 67
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids 66
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici 64
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer 60
Health related quality of life, anxiety and depression among patients with carcinoid tumors 60
Long-term survival and prognostic factors in neuroendocrine tumors: Results from a large multicenter study 57
Neuroendocrine markers and clinical aoutcome in 100 well differentiated (carcinoid) and 52 poorly differentiated lung neuroendocrine tymours. XXX Congresso Nazionale Societa' Italiana Endocrinologia 56
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids 56
Efficacy and safety of high dose OCTREOTIDE LAR treatment in patients with progressive well differentiated neuroendocrine tumors 56
La fisiopatologia del timo 55
Follow up e complicanze del trattamento medico della patologia surrenalica 55
Neuroendocrine features of well differentiated human neuroendocrine lung tumors - 6th European Congress of Endocrinology 54
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses. 54
Surgical treatment of well differentiated neuroendocrine tumours of the lung 53
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors - 52
EFFICACY AND SAFETY OF HIGH DOSES OF LONG-ACTING SOMATOSTATIN ANALOGUES FOR TREATMENT OF WELL DIFFERENTIATED FUNCTIONING NEUROENDOCRINE TUMORS 51
“Preliminary study of tumor size response to low and high doses cabergolina therapy in clinically non-functioning macroadenomas with different D2 receptor expression detected with 123-I-IBZM pituitary scintigraphy” 51
FDG-PET, I Metaiodobenylguanidine and 111 in DPTA-Octreotide: scintigraphy for detection of recurrent / residual medullary thyroid cancer 49
Surgical treatment of neuroendocrine tumors of the lung 49
GH-deficit in the developing age: critical analysis of the diagnostic tests 47
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. 47
In vitro” and “in vivo” somatostatin receptor subtype expression in well differentiated lung neuroendocrine tumors ( typical anc atypical brochial carcinoid) 45
Surgical treatment of neuroendocrine tumors of the lung. 2nd EACTS/ESTS Joint Meeting. 44
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. 44
Evaluation of the different role of 111 In -pentetreotide SPECT/CT of thorax and abdomen in investigating carcinoid tumours 44
Neuroendocrine prevalence in Thymic Tumors 43
macro-prolactinomas:which the therapeutic space of dopamine-agonists? 42
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice 41
Deficit di GH nell’età evolutiva : analisi critica dei test diagnostici 40
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA 39
Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors 39
Neuroendocrine Markers And Clinical Outcome In 100 Well Differentiated (Carcinoids) And 52 Poorly Differentiated Lung Neuroendocrine Tumours; 39
Efficacy and safety of high doses of long-acting somatostain analogues for treatment of well differentiated secreting neuroendocrine tumors 38
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors 38
Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid 37
Papillary thyroid carcinoma in a MEN 1 patient.” 37
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study 36
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer. 35
Postsurgical follow-up is always necessary in bronchial carcinoid 27
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY 27
Totale 3.055
Categoria #
all - tutte 11.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020195 0 0 0 0 41 8 42 3 41 21 16 23
2020/2021552 4 40 21 40 143 28 42 3 59 17 53 102
2021/2022500 9 86 11 30 10 4 3 152 82 5 50 58
2022/2023878 57 118 16 65 77 85 2 43 371 1 30 13
2023/2024311 20 29 27 4 3 3 70 7 48 10 36 54
2024/2025288 37 83 30 36 102 0 0 0 0 0 0 0
Totale 3.055